Article Details

FDA approves Sun Pharma's JAK inhibitor for alopecia - Pharmaceutical Technology

Retrieved on: 2024-07-27 06:41:18

Tags for this article:

Click the tags to see associated articles and topics

FDA approves Sun Pharma's JAK inhibitor for alopecia - Pharmaceutical Technology. View article details on hiswai:

Summary

The article discusses the FDA approval of Sun Pharma's JAK inhibitor Leqselvi for treating alopecia areata. Business intelligence highlights include market forecasts, safety concerns, and the potential $253m revenue by 2030.

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up